BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28007842)

  • 1. MANAGEMENT OF ENDOCRINE DISEASE: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis.
    Pergialiotis V; Konstantopoulos P; Prodromidou A; Florou V; Papantoniou N; Perrea DN
    Eur J Endocrinol; 2017 Mar; 176(3):R159-R166. PubMed ID: 28007842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS.
    Trakakis E; Pergialiotis V; Hatziagelaki E; Panagopoulos P; Salloum I; Papantoniou N
    Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28672734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study.
    Shi D; Du J; Kang H; Feng L; Liu F
    Gynecol Endocrinol; 2024 Dec; 40(1):2358219. PubMed ID: 38835150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study.
    Bedaiwy MA; Abdel-Rahman MY; Tan J; AbdelHafez FF; Abdelkareem AO; Henry D; Lisonkova S; Hurd WW; Liu JH
    J Womens Health (Larchmt); 2018 May; 27(5):659-664. PubMed ID: 29620956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S; Chander R; Jain A; Garg T; Yadav P
    JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.
    Pei YJ; Wang AM; Zhao Y; Yan L; Li M; White RE; Han GC
    Gynecol Endocrinol; 2014 Aug; 30(8):553-6. PubMed ID: 24884959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical Hypothyroidism Impact on the Characteristics of Patients with Polycystic Ovary Syndrome. A Meta-Analysis of Observational Studies.
    de Medeiros SF; de Medeiros MAS; Ormond CM; Barbosa JS; Yamamoto MMW
    Gynecol Obstet Invest; 2018; 83(2):105-115. PubMed ID: 30025406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?
    Celik C; Abali R; Tasdemir N; Guzel S; Yuksel A; Aksu E; Yılmaz M
    Gynecol Endocrinol; 2012 Aug; 28(8):615-8. PubMed ID: 22329744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
    Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
    Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
    Tagliaferri V; Romualdi D; Guido M; Mancini A; De Cicco S; Di Florio C; Immediata V; Di Segni C; Lanzone A
    Eur J Endocrinol; 2016 Nov; 175(5):433-41. PubMed ID: 27511825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical hypothyroidism is not a risk factor for polycystic ovary syndrome in obese women of reproductive age.
    Zhang B; Wang J; Shen S; Liu J; Sun J; Gu T; Zhu D; Bi Y
    Gynecol Endocrinol; 2018 Oct; 34(10):875-879. PubMed ID: 29658805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.
    Benetti-Pinto CL; Berini Piccolo VR; Garmes HM; Teatin Juliato CR
    Fertil Steril; 2013 Feb; 99(2):588-92. PubMed ID: 23103018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters.
    Franik G; Bizoń A; Włoch S; Pluta D; Blukacz Ł; Milnerowicz H; Madej P
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4755-4761. PubMed ID: 29164590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.
    Zhang YF; Yang YS; Hong J; Gu WQ; Shen CF; Xu M; Du PF; Li XY; Ning G
    Endocrine; 2006 Jun; 29(3):419-23. PubMed ID: 16943580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Vitamin D supplementation on hormonal and glycaemic profile of patients with PCOS: A meta-analysis of randomised trials.
    Pergialiotis V; Karampetsou N; Panagopoulos P; Trakakis E; Papantoniou N
    Int J Clin Pract; 2017 Jun; 71(6):. PubMed ID: 28524342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.